“M ove to the back if you’ve lost your life savings to the drug companies,” shouts a woman walking by your correspondent. A spirited group follows her to the end of a long queue for a Senate hearing on insulin prices on May 10th. In the room David Ricks of Eli Lilly, a large American drug firm, testifies that insulin, used to regulate blood-sugar levels for diabetics, is cheap and even free in some instances. “If you contact Lilly today, we will ship you a month’s supply at no cost with one question: ‘What’s your address?’” he says. Those dressed in gear with slogans like “Insulin for All” shake their heads in disbelief. Drug companies may be offering cheap insulin, but it is not reaching all patients.
“如果您损失了给制药公司的生命储蓄，”一名妇女在您的通讯员走来走去时大喊。一个充满活力的团体跟随她到5月10日关于胰岛素价格的参议院听证会结束。美国大型药品公司Eli Lilly的David Ricks在房间里作证说，胰岛素用来调节血糖水平的糖尿病患者，在某些情况下很便宜，甚至是免费的。他说：“如果您今天与礼来公司联系，我们将免费为您发送一个月的供应，一个问题：'您的地址是什么？’。”那些穿着齿轮的人，例如“所有人的胰岛素”，令人难以置信地摇了摇头。制药公司可能会提供廉价的胰岛素，但并未吸引所有患者。
